Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126156261 | 12615626 | 1 | I | 20160713 | 20160802 | 20160802 | PER | US-PFIZER INC-2016344166 | PFIZER | 76.00 | YR | F | Y | 0.00000 | 20160802 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
126156261 | 12615626 | 1 | PS | NEURONTIN | GABAPENTIN | 1 | 400 MG, 3X/DAY | U | 20235 | 400 | MG | TID | |||||||
126156261 | 12615626 | 2 | C | AMITRIPTYLINE | AMITRIPTYLINE | 1 | 25 MG, 1X/DAY | 0 | 25 | MG | TABLET | QD | |||||||
126156261 | 12615626 | 3 | C | CLORAZEPATE | CLORAZEPATE DIPOTASSIUM | 1 | 7.5 MG, 1X/DAY | 0 | 7.5 | MG | TABLET | QD |
Indications of drugs used
no results found |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
126156261 | 12615626 | Drug ineffective |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
no results found |